Weekly Recap | Twist Bioscience +3.19%, consensus target below spotWeekly Review·Oct 3, 2026 at 08:40 AMTWST+6.81%
Weekly Recap | Alnylam Pharma -14.16%, one-way sellingWeekly Review·Oct 3, 2026 at 08:28 AMALNY-1.37%
Weekly Recap | RXRX.US +10.16%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:37 AMRXRX+15.53%
Weekly Recap | Roche -4.04%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:34 AMRHHBY+0.48%
Weekly Recap | PURR.US -7.47%, consensus target above spotWeekly Review·Oct 3, 2026 at 07:30 AMPURR+7.44%
Weekly Recap | Kodiak Sciences +191.96%, Zenkuda hits phase 3 goalWeekly Review·Oct 3, 2026 at 07:06 AMKOD+0.64%
Weekly Recap | BioNTech SE this week, CEO trims shares repeatedlyWeekly Review·Oct 3, 2026 at 06:25 AMBNTX-0.33%
Weekly Recap | ABSI.US +13.66%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 06:09 AMABSI+0.54%
Weekly Recap | SPDR S&P Biotech -0.39%, busy week of biotech headlinesWeekly Review·Oct 3, 2026 at 05:05 AMXBI+0.07%
Weekly Recap | ARKG.US +1.2%, closing in on record highsWeekly Review·Oct 3, 2026 at 04:10 AMARKG+2.72%
The Nasdaq Biotechnology Index fell by more than 1%. Among the constituent stocks, Lyell Immunopharma dropped 11.28%, Vor Biopharma fell 8.16%, Alumis decreased 6.99%, and Oruka Therapeutics declined 7.93%. Meanwhile, Coherus BioSciences rose 6.34%, Pyxis Oncology increased 8.02%, Ultragenyx Pharmaceutical gained 13.59%, and Jyong Biotech surged 43.38%Wallstreetcn·Dec 30, 2025 at 07:31 PMLYEL-4.54%PYXS+2.57%
The Nasdaq Biotechnology Index fell by more than 2%. Among them, Sutro Biopharma dropped 12.98%, Kyverna Therapeutics fell 10.95%, GRAIL decreased 10.01%, and Pyxis Oncology declined 9.34%. Ironwood Pharma rose 4.44%, Arrowhead Pharmaceuticals increased 4.63%, Neumora Therapeutics grew 6.92%, and Q32 Bio surged 92.69%Wallstreetcn·Dec 1, 2025 at 05:39 PMIRWD-0.55%STRO-3.49%
The Nasdaq Biotechnology Index fell by 2.3%. Among the constituent stocks, uniQure NV had the largest decline, reaching 55.76%; Tscan Therapeutics fell by 42.27%; Alvotech dropped by 30.72%; Neurogene decreased by 16.87%. On the other hand, Hutchison China MediTech (HCM) rose by 3.10%, Indivior increased by 4.29%, Acrivon Therapeutics went up by 8.79%, Pyxis Oncology climbed by 11.97%, and Terns Pharmaceuticals surged by 81.84%Wallstreetcn·Nov 3, 2025 at 04:04 PMPYXS+2.57%TERN0.00%
